These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5864)

  • 1. Some biological activities of rabbit anti-interferon serum.
    Fuchsberger N; Styk B; Borecký L; Hajnická V
    Acta Virol; 1976 Apr; 20(2):107-13. PubMed ID: 5864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some biological activites of rabbit anti-interferon serum.
    Fuchsberger N; Borecký L; Hajnická V; Styk B
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):715-8. PubMed ID: 597018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of sera obtained by hyperimmunizing rabbits with interferon from mouse L cells.
    Kisielow B; Inglot AD; Chudzio T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):37-44. PubMed ID: 444043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions.
    Fuchsberger N; Hajnická V; Boreckyý L
    Acta Virol; 1975 Jan; 19(1):59-66. PubMed ID: 235199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the primary in vitro antibody response by interferon preparations.
    Johnson HM; Smith BG; Baron S
    J Immunol; 1975 Jan; 114(1 Pt 2):403-9. PubMed ID: 1090660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing and non-neutralizing antibodies to bovine thyroid-stimulating hormone and its subunits.
    Beall GN; Chopra IJ; Solomon DH; Pierce JG; Cornell JS
    J Clin Invest; 1973 Dec; 52(12):2979-85. PubMed ID: 4750435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of interferon covalently bound to sepharose.
    Ankel H; Chany C; Galliot B; Chevalier MJ; Robert M
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2360-3. PubMed ID: 4365374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytotoxic factors by immunization of mice with Freund's adjuvant components.
    Baumal R; Marks A; Mahony J; Bose A
    Cancer Res; 1980 May; 40(5):1630-5. PubMed ID: 6966183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formation and persistence of latex-agglutination-inhibiting IgG- and IgM-antibodies in rabbits inoculated with poliomyelitis, Coxsackie and encephalomyocarditis viruses (author's transl)].
    Brade H; Klein M; Schmidt WA
    Zentralbl Bakteriol Orig A; 1975 Oct; 233(2):139-46. PubMed ID: 175613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-neutralizing or enhancing activities in hybridoma cell fluids after in vitro immunization.
    Stancek D; Stanceková M; Pimenta JK; Reis D
    Acta Virol; 1992 Aug; 36(4):376-82. PubMed ID: 1282778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of mouse natural killer cell activity by type II interferon.
    Senik A; Stefanos S; Kolb JP; Lucero M; Falcoff E
    Ann Immunol (Paris); 1980; 131C(3):349-61. PubMed ID: 6157349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of antibodies against mouse immune T (type II) interferon and their neutralizing properties.
    Stefanos S; Catinot L; Wietzerbin J; Falcoff E
    J Gen Virol; 1980 Sep; 50(1):225-9. PubMed ID: 6160201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of mouse interferon on specifically purified immunoadsorbent.
    Hajnicka V; Fuchsberger N; Borecký L
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):619-22. PubMed ID: 597010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.
    Reif AE; Robinson CM
    Immunology; 1975 Jan; 28(1):199-205. PubMed ID: 1090519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raising antibodies to human leukocyte interferon.
    Mogensen KE; Pyhälä L; Cantell K
    Acta Pathol Microbiol Scand B; 1975 Oct; 83(5):443-50. PubMed ID: 1180059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the anticellular and antiviral effects of interferon and the haemopoietic stem cell inhibition factor.
    Orlova TG; Golovanova TA; Shcheglovitova ON; Mysyakin EB; Bokhonko AI; Kaulen DR
    Acta Virol; 1979 May; 23(3):177-82. PubMed ID: 41429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cytophilic antibodies. A mouse serum "antibody" having an affinity for macrophages and fast alpha-globulin mobility.
    Nelson DS
    Aust J Exp Biol Med Sci; 1970 Jun; 48(3):329-41. PubMed ID: 4194820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.